نتایج جستجو برای: beclin1

تعداد نتایج: 478  

Journal: :Cell 2013
Joungmok Kim Young Chul Kim Chong Fang Ryan C. Russell Jeong Hee Kim Weiliang Fan Rong Liu Qing Zhong Kun-Liang Guan

Autophagy is a stress response protecting cells from unfavorable conditions, such as nutrient starvation. The class III phosphatidylinositol-3 kinase, Vps34, forms multiple complexes and regulates both intracellular vesicle trafficking and autophagy induction. Here, we show that AMPK plays a key role in regulating different Vps34 complexes. AMPK inhibits the nonautophagy Vps34 complex by phosph...

2015
Santosh Chauhan Zahra Ahmed Steven B. Bradfute John Arko-Mensah Michael A. Mandell Seong Won Choi Tomonori Kimura Fabien Blanchet Anna Waller Michal H. Mudd Shanya Jiang Larry Sklar Graham S. Timmins Nicole Maphis Kiran Bhaskar Vincent Piguet Vojo Deretic

Autophagy is a conserved homeostatic process active in all human cells and affecting a spectrum of diseases. Here we use a pharmaceutical screen to discover new mechanisms for activation of autophagy. We identify a subset of pharmaceuticals inducing autophagic flux with effects in diverse cellular systems modelling specific stages of several human diseases such as HIV transmission and hyperphos...

2012
Xiaohua Li Liqiang He Ka Hing Che Sarah F. Funderburk Lifeng Pan Nina Pan Mingjie Zhang Zhenyu Yue Yanxiang Zhao

Beclin 1 is a core component of the Class III Phosphatidylinositol 3-Kinase VPS34 complex. The coiled coil domain of Beclin 1 serves as an interaction platform for assembly of distinct Atg14L- and UVRAG-containing complexes to modulate VPS34 activity. Here we report the crystal structure of the coiled coil domain that forms an antiparallel dimer and is rendered metastable by a series of 'imperf...

Journal: :Neuron 2002
Zhenyu Yue Antony Horton Monica Bravin Philip L. DeJager Fekrije Selimi Nathaniel Heintz

Autophagy is a pathway for bulk degradation of subcellular constituents that is hyperactivated in many neurodegenerative conditions. It has been considered a second form of programmed cell death. Death of cerebellar Purkinje cells in lurcher animals is due to a mutation in GluRdelta2 that results in its constitutive activation. Here we have identified protein interactions between GluRdelta2, a ...

2017
Shuji Wakatsuki Shinji Tokunaga Megumi Shibata Toshiyuki Araki

Macroautophagy is a catabolic process, in which portions of cytoplasm or organelles are delivered to lysosomes for degradation. Emerging evidence has indicated a pathological connection between axonal degeneration and autophagy. However, the physiological function and induction mechanism of autophagy in axons remain elusive. We herein show that, through activation of BECLIN1, glycogen synthase ...

2017
Guozhong Cui Meng Yang Liang Chen Wenhua Yang

Background: Thyroid papillary carcinoma is the most common clinical thyroid malignancy. Autophagy is related to the occurrence and development of tumors. However, there is no report about the correlation between autophagy protein expression and biological characteristics of thyroid papillary carcinoma and lymph node metastasis. Therefore, the authors studied the relationship between autophagy p...

Journal: :Cell host & microbe 2009
Shahab Shahnazari John H Brumell

The mechanism by which the cell responds to invading pathogens is an area of intense research. Joubert et al. (2009) have found that the phagocytic receptor CD46 is able to activate autophagy through a tripartite interaction between itself, a scaffold protein GOPC, and the autophagy inducer complex of Beclin1-VPS34.

H. Zhao, J. Lian, J.J. Chen, L.F. Li, M.Y. Chen, R. Xing, R.Q. Liu, W. Huang, X. Zhou, Y.C. Zeng, Y.Z. Xie,

Background: Tumor radioresistance leads to a reduction in the efficiency of radiation therapy. It is very important to explore the cellular mechanisms leading to radioresistance and to find potential therapeutic targets, which might improve the efficacy of radiation therapy. This study was to investigate the role of ataxia-telangiectasia mutated (ATM) and murine double minute X (MDMX) in radior...

2016
Mehrad Tavallai Laurence Booth Jane L. Roberts Andrew Poklepovic Paul Dent

We determined whether the approved myelofibrosis drug ruxolitinib (Jakafi(®)), an inhibitor of Janus kinases 1/2 (JAK1 and JAK2), could be repurposed as an anti-cancer agent for solid tumors. Ruxolitinib synergistically interacted with dual ERBB1/2/4 inhibitors to kill breast as well as lung, ovarian and brain cancer cells. Knock down of JAK1/2 or of ERBB1/2/3/4 recapitulated on-target drug eff...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید